Search research articles
Contact Us
Filters
Showing results (1-10 of 276) with videos related to
Page
of 28
Sort By:
Reviews on Recent Clinical Trials
|
March 3, 2020
COVID-19: Perspectives on the Potential Novel Global Threat
Ivan Gentile, Ludovico Abenavoli
Journal of Hepatology
|
March 30, 2010
Surrogate endpoints and non-inferiority trials in chronic viral hepatitis
Ivan Gentile, Guglielmo Borgia
The Lancet. Infectious Diseases
|
April 13, 2015
A pill a day keeps HCV away
Ivan Gentile, Guglielmo Borgia
International Journal of Women'S Health
|
June 27, 2014
Vertical transmission of hepatitis B virus: challenges and solutions
Ivan Gentile, Guglielmo Borgia
Diseases (Basel, Switzerland)
|
March 28, 2023
COVID-19: Where We Are and Where We Are Going
Ludovico Abenavoli, Ivan Gentile
Expert Review of Anti-Infective Therapy
|
August 11, 2010
Development and progression of gastroesophageal varices in patients with chronic hepatitis C
Ivan Gentile, Guglielmo Borgia
Liver International : Official Journal of the International Association for the Study of the Liver
|
August 17, 2010
Noninvasive prediction of oesophageal varices: as simple as blood count?
Ivan Gentile, Dominique Thabut
Evidence-Based Medicine
|
July 17, 2014
Ledipasvir/Sofosbuvir administration achieves very high rate of viral clearance in patients with HCV genotype 1 infection without cirrhosis, regardless of ribavirin co-administration or length of treatment
Ivan Gentile, Guglielmo Borgia
Plos Medicine
|
January 28, 2022
COVID-19 prophylaxis in immunosuppressed patients: Beyond vaccination
Ivan Gentile, Nicola Schiano Moriello
BMC Infectious Diseases
|
March 9, 2010
Is the drug-induced hypersensitivity syndrome (DIHS) due to human herpesvirus 6 infection or to allergy-mediated viral reactivation? Report of a case and literature review
Ivan Gentile, Maria Talamo, Guglielmo Borgia
Page
of 28
Search research articles
Search
Showing results (1-10 of 276) with videos related to
Sort By:
Page
of 28
Reviews on Recent Clinical Trials
|
March 3, 2020
COVID-19: Perspectives on the Potential Novel Global Threat
Ivan Gentile, Ludovico Abenavoli
Journal of Hepatology
|
March 30, 2010
Surrogate endpoints and non-inferiority trials in chronic viral hepatitis
Ivan Gentile, Guglielmo Borgia
The Lancet. Infectious Diseases
|
April 13, 2015
A pill a day keeps HCV away
Ivan Gentile, Guglielmo Borgia
International Journal of Women'S Health
|
June 27, 2014
Vertical transmission of hepatitis B virus: challenges and solutions
Ivan Gentile, Guglielmo Borgia
Diseases (Basel, Switzerland)
|
March 28, 2023
COVID-19: Where We Are and Where We Are Going
Ludovico Abenavoli, Ivan Gentile
Expert Review of Anti-Infective Therapy
|
August 11, 2010
Development and progression of gastroesophageal varices in patients with chronic hepatitis C
Ivan Gentile, Guglielmo Borgia
Liver International : Official Journal of the International Association for the Study of the Liver
|
August 17, 2010
Noninvasive prediction of oesophageal varices: as simple as blood count?
Ivan Gentile, Dominique Thabut
Evidence-Based Medicine
|
July 17, 2014
Ledipasvir/Sofosbuvir administration achieves very high rate of viral clearance in patients with HCV genotype 1 infection without cirrhosis, regardless of ribavirin co-administration or length of treatment
Ivan Gentile, Guglielmo Borgia
Plos Medicine
|
January 28, 2022
COVID-19 prophylaxis in immunosuppressed patients: Beyond vaccination
Ivan Gentile, Nicola Schiano Moriello
BMC Infectious Diseases
|
March 9, 2010
Is the drug-induced hypersensitivity syndrome (DIHS) due to human herpesvirus 6 infection or to allergy-mediated viral reactivation? Report of a case and literature review
Ivan Gentile, Maria Talamo, Guglielmo Borgia
Page
of 28